BMS-986528 Clinical Trials (2026): 1 Studies for Arthritis, Rheumatoid
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 BMS-986528 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Arthritis, Rheumatoid) and 84 total planned enrollment. 1 BMS-986528 clinical trial is actively recruiting. Most recent activity: NCT07412704 (Sep 2030).
BMS-986528 clinical trials at a glance: phase × recruitment status
| Phase | not yet recruiting | Total |
|---|---|---|
| P1/P2 | 1 | 1 |
Recruiting BMS-986528 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07412704 | A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis | P1/P2 | Arthritis, Rheumatoid | 84 | May 2026 |
All BMS-986528 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07412704 | A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis | P1/P2 | not yet recruiting | 84 | Bristol-Myers Squibb | May 2026 |
BMS-986528 clinical trials: frequently asked questions
- How many BMS-986528 clinical trials are there?
- 1 BMS-986528 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are BMS-986528 clinical trials recruiting in 2026?
- No active BMS-986528 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is BMS-986528 being studied for?
- BMS-986528 is being studied for Arthritis, Rheumatoid. The trials are grouped by indication on this page.
- Who sponsors BMS-986528 clinical trials?
- The lead sponsor across the most BMS-986528 trials is Bristol-Myers Squibb. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming BMS-986528as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: